We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current APLT market cap is 91.58M. The company's latest EPS is USD -1.0293 and P/E is -0.78.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | -667k | 190k | 144k | 121k |
| Operating Income | -15.49M | -21.01M | -21.09M | -20.44M | -29.74M |
| Net Income | -42.37M | -37.68M | -83.94M | 2.9M | -68.59M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 9.99M |
| Operating Income | -45.58M | -94.47M | -105.62M | -82.95M | -64.54M |
| Net Income | -45.51M | -93.96M | -105.58M | -82.51M | -119.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 45.2M | 54.83M | 151.23M | 127.78M | 106.57M |
| Total Liabilities | 56.24M | 71.98M | 83.94M | 55.39M | 100.67M |
| Total Equity | -11.04M | -17.15M | 67.29M | 72.39M | 5.89M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 48.39M | 104.51M | 89.89M | 38.36M | 54.83M |
| Total Liabilities | 15.78M | 22.57M | 27.35M | 34.3M | 71.98M |
| Total Equity | 32.61M | 81.94M | 62.54M | 4.06M | -17.15M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -38.17M | -55.17M | -18.91M | -41.51M | -64.84M |
| Investing | 13.87M | 13.87M | N/A | N/A | N/A |
| Financing | 45.1M | 74.54M | 115.5M | 113.81M | 113.81M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -36.31M | -78.21M | -90.73M | -78.09M | -55.17M |
| Investing | -20.01M | -19.47M | 12.43M | 13.17M | 13.87M |
| Financing | 56.42M | 136.29M | 74.72M | 27.69M | 74.54M |
| Market Cap | 91.58M |
| Price to Earnings Ratio | -0.78 |
| Price to Sales Ratio | 9.31 |
| Price to Cash Ratio | 1.87 |
| Price to Book Ratio | -5.43 |
| Dividend Yield | - |
| Shares Outstanding | 116.36M |
| Average Volume (1 week) | 5.72M |
| Average Volume (1 Month) | 10.38M |
| 52 Week Change | -76.50% |
| 52 Week High | 10.6237 |
| 52 Week Low | 0.7726 |
| Spread (Intraday) | 0 (0.34%) |
| Company Name | Applied Therapeutics Inc |
| Address |
3411 silverside road tatnall wilmington, delaware 19810 |
| Website | https://www.appliedtherapeutics.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
